Ionis Pharmaceuticals Inc (NASDAQ:IONS)
| 46.26 Delayed Data As of Sep 28 |  -0.87 / -1.85%Today’s Change | 32.69 Today|||52-Week Range 47.74 | +22.48% Year-to-Date |
Latest IONS News | Press Releases
| Insider Sell: Director B Parshall Sells 10,000 Shares of Ionis Pharmaceuticals Inc 3:01am / GuruFocus News - Paid Partner Content | Ionis (IONS) Meets Rare Disease Drug Study Goal, Stock Up 8.5% Sep 27 / Zacks.com - Paid Partner Content |
| Ionis (IONS) Inks New Deal With Roche to Develop Novel RNA Drugs Sep 28 / Zacks.com - Paid Partner Content | Strength Seen in Ionis Pharmaceuticals (IONS): Can Its 8.5% Jump Turn into More Strength? Sep 27 / Zacks.com - Paid Partner Content |
| Biotech Stock Roundup: ICPT Up on Buyout Deal, IMVT & PLRX Gain on Study Data Sep 28 / Zacks.com - Paid Partner Content |
